SENORES PHARMACEUTICALS L (SENORES) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.029x

Based on the latest financial reports, SENORES PHARMACEUTICALS L (SENORES) has a cash flow conversion efficiency ratio of 0.029x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs242.20 Million ≈ $2.62 Million USD) by net assets (Rs8.34 Billion ≈ $90.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

SENORES PHARMACEUTICALS L - Cash Flow Conversion Efficiency Trend (2022–2025)

This chart illustrates how SENORES PHARMACEUTICALS L's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does SENORES PHARMACEUTICALS L carry for a breakdown of total debt and financial obligations.

SENORES PHARMACEUTICALS L Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of SENORES PHARMACEUTICALS L ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Jiangling Motors Corp Ltd SHE:200550	0.212x
Clientele JSE:CLI	-0.059x
Taimide Tech Inc TW:3645	0.071x
Shenzhen Changfang Light Emitting SHE:300301	-0.028x
W-SCOPE CHUNGJU PLANT LTD (PROPOSE KQ:393890	0.012x
Jiangsu Tongda Power Technology Co Ltd SHE:002576	0.007x
Ege Endustri ve Ticaret AS IS:EGEEN	0.030x
Soltec Power Holdings S.A MC:SOL	-0.138x

Annual Cash Flow Conversion Efficiency for SENORES PHARMACEUTICALS L (2022–2025)

The table below shows the annual cash flow conversion efficiency of SENORES PHARMACEUTICALS L from 2022 to 2025. For the full company profile with market capitalisation and key ratios, see SENORES company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs94.96 Million ≈ $1.03 Million	Rs-459.20 Million ≈ $-4.97 Million	-4.836x	-4260.01%
2024-03-31	Rs2.32 Billion ≈ $25.06 Million	Rs-257.00 Million ≈ $-2.78 Million	-0.111x	-367.70%
2023-03-31	Rs454.99 Million ≈ $4.92 Million	Rs-10.79 Million ≈ $-116.69K	-0.024x	+91.69%
2022-03-31	Rs365.90 Million ≈ $3.96 Million	Rs-104.47 Million ≈ $-1.13 Million	-0.286x	--

About SENORES PHARMACEUTICALS L

NSE:SENORES India Drug Manufacturers - General

Market Cap

$447.85 Million

Rs41.41 Billion INR

Market Cap Rank

#13131 Global

#617 in India

Share Price

Rs899.20

Change (1 day)

-0.48%

52-Week Range

Rs483.75 - Rs939.75

All Time High

Rs939.75